Literature DB >> 21889481

RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2.

Karlie Jones1, Bingwen Jin, Polina Iakova, Claudia Huichalaf, Partha Sarkar, Christiane Schneider-Gold, Benedikt Schoser, Giovanni Meola, Ann-Bin Shyu, Nikolai Timchenko, Lubov Timchenko.   

Abstract

Expansions of noncoding CUG and CCUG repeats in myotonic dystrophies type 1 (DM1) and DM2 cause complex molecular pathology, the features of which include accumulation of RNA aggregates and misregulation of the RNA-binding proteins muscleblind-like 1 (MBNL1) and CUG-binding protein 1 (CUGBP1). CCUG repeats also decrease amounts of the nucleic acid binding protein ZNF9. Using tetracycline (Tet)-regulated monoclonal cell models that express CUG and CCUG repeats, we found that low levels of long CUG and CCUG repeats result in nuclear and cytoplasmic RNA aggregation with a simultaneous increase of CUGBP1 and a reduction of ZNF9. Elevation of CUGBP1 and reduction of ZNF9 were also observed before strong aggregation of the mutant CUG/CCUG repeats. Degradation of CUG and CCUG repeats normalizes ZNF9 and CUGBP1 levels. Comparison of short and long CUG and CCUG RNAs showed that great expression of short repeats form foci and alter CUGBP1 and ZNF9; however, long CUG/CCUG repeats misregulate CUGBP1 and ZNF9 much faster than high levels of the short repeats. These data suggest that correction of DM1 and DM2 might be achieved by complete and efficient degradation of CUG and CCUG repeats or by a simultaneous disruption of CUG/CCUG foci and correction of CUGBP1 and ZNF9.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889481      PMCID: PMC3204036          DOI: 10.1016/j.ajpath.2011.07.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Rapid deadenylation triggered by a nonsense codon precedes decay of the RNA body in a mammalian cytoplasmic nonsense-mediated decay pathway.

Authors:  Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

2.  Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts.

Authors:  B M Davis; M E McCurrach; K L Taneja; R H Singer; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

5.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

6.  RNA leaching of transcription factors disrupts transcription in myotonic dystrophy.

Authors:  A Ebralidze; Y Wang; V Petkova; K Ebralidse; R P Junghans
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

7.  Absence of a differentiation defect in muscle satellite cells from DM2 patients.

Authors:  Richard Pelletier; Frederic Hamel; Daniel Beaulieu; Lysanne Patry; Caroline Haineault; Mark Tarnopolsky; Benedikt Schoser; Jack Puymirat
Journal:  Neurobiol Dis       Date:  2009-07-24       Impact factor: 5.996

8.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

9.  The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy.

Authors:  Libin Zhang; Jerome E Lee; Jeffrey Wilusz; Carol J Wilusz
Journal:  J Biol Chem       Date:  2008-06-16       Impact factor: 5.157

10.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  21 in total

Review 1.  The role of CUGBP1 in age-dependent changes of liver functions.

Authors:  Karlie Jones; Lubov Timchenko; Nikolai A Timchenko
Journal:  Ageing Res Rev       Date:  2012-03-14       Impact factor: 10.895

2.  Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology.

Authors:  Christopher J Holler; Paulina R Davis; Tina L Beckett; Thomas L Platt; Robin L Webb; Elizabeth Head; M Paul Murphy
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2.

Authors:  M Giagnacovo; M Malatesta; R Cardani; G Meola; C Pellicciari
Journal:  Histochem Cell Biol       Date:  2012-06-17       Impact factor: 4.304

4.  GSK3β mediates muscle pathology in myotonic dystrophy.

Authors:  Karlie Jones; Christina Wei; Polina Iakova; Enrico Bugiardini; Christiane Schneider-Gold; Giovanni Meola; James Woodgett; James Killian; Nikolai A Timchenko; Lubov T Timchenko
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

Review 5.  Molecular mechanisms of muscle atrophy in myotonic dystrophies.

Authors:  Lubov Timchenko
Journal:  Int J Biochem Cell Biol       Date:  2013-06-21       Impact factor: 5.085

6.  Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5.

Authors:  Karlie Jones; Christina Wei; Benedikt Schoser; Giovanni Meola; Nikolai Timchenko; Lubov Timchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

Review 7.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

8.  Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.

Authors:  Mei Wang; Wen-Chin Weng; Lauren Stock; Diana Lindquist; Ana Martinez; Genevieve Gourdon; Nikolai Timchenko; Mike Snape; Lubov Timchenko
Journal:  Mol Cell Biol       Date:  2019-10-11       Impact factor: 4.272

9.  Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.

Authors:  Yuan Fu; Kali A Miller; Lien Nguyen; Amin Haghighat Jahromi; Long M Luu; Anne M Baranger; Steven C Zimmerman
Journal:  J Med Chem       Date:  2013-11-21       Impact factor: 7.446

10.  Synaptopathy Mechanisms in ALS Caused by C9orf72 Repeat Expansion.

Authors:  Agnes L Nishimura; Natalia Arias
Journal:  Front Cell Neurosci       Date:  2021-06-01       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.